Biohaven Pharmaceutical (NYSE:BHVN) reported quarterly losses of $(3.82) per share. This is a 45.8 percent decrease over losses of $(2.62) per share from the same period last year.
P/E Ratio Insights for Becton Dickinson
In the current market session, Becton Dickinson Inc. (NYSE:BDX) price is at $236.09, after a 1.04% increase. However,…